Recent advancements in optical biosensors for cancer detection

B Kaur, S Kumar, BK Kaushik - Biosensors and Bioelectronics, 2022 - Elsevier
Optical biosensors are rapid, real-time, and portable, have a low detection limit and a high
sensitivity, and have a great potential for diagnosing various types of cancer. Optical …

[HTML][HTML] Small extracellular vesicles in cancer

K Abhange, A Makler, Y Wen, N Ramnauth, W Mao… - Bioactive Materials, 2021 - Elsevier
Extracellular vesicles (EV) are lipid-bilayer enclosed vesicles in submicron size that are
released from cells. A variety of molecules, including proteins, DNA fragments, RNAs, lipids …

Breast cancer screening for women at higher-than-average risk: updated recommendations from the ACR

DL Monticciolo, MS Newell, L Moy, CS Lee… - Journal of the American …, 2023 - Elsevier
Early detection decreases breast cancer death. The ACR recommends annual screening
beginning at age 40 for women of average risk and earlier and/or more intensive screening …

Novel approaches to screening for breast cancer

RM Mann, R Hooley, RG Barr, L Moy - Radiology, 2020 - pubs.rsna.org
Screening for breast cancer reduces breast cancer–related mortality and earlier detection
facilitates less aggressive treatment. Unfortunately, current screening modalities are …

Surface plasmon resonance (SPR) sensor for cancer biomarker detection

S Das, R Devireddy, MR Gartia - Biosensors, 2023 - mdpi.com
A biomarker is a physiological observable marker that acts as a stand-in and, in the best-
case scenario, forecasts a clinically significant outcome. Diagnostic biomarkers are more …

Towards sense and sensitivity-based electrochemical biosensors for liquid biopsy-based breast cancer detection

S Singh, A Miglione, A Raucci, A Numan… - TrAC Trends in Analytical …, 2023 - Elsevier
Rapid diagnosis is an important “pillar” in the fight against breast cancer. The ultimate goal
of early detection is to find tumors before they reach a malignant stage. In recent decades, a …

Do we still need breast cancer screening in the era of targeted therapies and precision medicine?

RM Trimboli, P Giorgi Rossi, NML Battisti, A Cozzi… - Insights into …, 2020 - Springer
Breast cancer (BC) is the most common female cancer and the second cause of death
among women worldwide. The 5-year relative survival rate recently improved up to 90% due …

[图书][B] Optical fiber-based plasmonic biosensors: trends, techniques, and applications

S Kumar, N Agrawal, C Saha, R Jha - 2022 - taylorfrancis.com
This book discusses the history, physics, fundamental principles, sensing technologies, and
characterization of plasmonic phenomenon-based fiber-optic biosensors, using optic …

[HTML][HTML] Fluorescent carbon quantum dots for effective tumor diagnosis: A comprehensive review

BD Latha, K Soumya, N More, C Mounika… - Biomedical Engineering …, 2023 - Elsevier
Abstract The Fluorescent Carbon Quantum Dots (FCQDs) have been extensively explored
for medical applications. Primarily, the research concentrated on diagnosis, imaging, and …

[HTML][HTML] Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?

X Gong, H Zhang, X Liu, Y Liu, J Liu… - Frontiers in Aging …, 2022 - frontiersin.org
The preclinical diagnosis and clinical practice for Alzheimer's disease (AD) based on liquid
biopsy have made great progress in recent years. As liquid biopsy is a fast, low-cost, and …